Macrophage death and defective inflammation resolution in atherosclerosis
Food and Drug Administration (FDA) approved a generic version of Saxenda, a commonly prescribed glucagon-like peptide-1 receptor agonist (GLP-1)
Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials
According to published studies, cell therapy still faces significant challenges in terms oflong-term safety, treatment durability, cell preparation and cost, individual variability, and delivery methods [149]
Similarly, pH-sensitive optical probes have been used to map extracellular acidification associated with increased glycolytic flux and poor vascular perfusion (185, 186)
While the potential mechanisms of action of hexarelin are still under scrutiny, researchers are hopeful that these pathways can be leveraged even more beneficially in the future [2]